Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,747 | -91,353 | -77,052 | -15,392 | -47,453 |
| Depreciation Amortization | 62,317 | 50,630 | 49,783 | 320 | 1,592 |
| Accounts receivable | -437 | -532 | -580 | -668 | -6 |
| Accounts payable and accrued liabilities | -111 | 817 | 646 | -140 | -312 |
| Other Working Capital | 1,640 | 823 | -11 | -1,165 | -1,221 |
| Other Operating Activity | 11,972 | 9,591 | 6,837 | 4,892 | 12,062 |
| Operating Cash Flow | $-38,366 | $-30,024 | $-20,377 | $-12,153 | $-35,338 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,738 | 37,738 | 37,738 | 37,738 | -38,577 |
| PPE Investments | -2,412 | -1,488 | -1,126 | -122 | -2,992 |
| Net Acquisitions | 3,449 | 3,449 | 3,449 | N/A | N/A |
| Investing Cash Flow | $38,775 | $39,699 | $40,061 | $37,616 | $-41,569 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100 | 100 | N/A | N/A | N/A |
| Common Stock Issued | 949 | 746 | 349 | 262 | 139,287 |
| Other Financing Activity | -493 | -493 | 0 | 0 | -427 |
| Financing Cash Flow | $556 | $353 | $349 | $262 | $138,860 |
| Exchange Rate Effect | -143 | -105 | -79 | 9 | -9 |
| Beginning Cash Position | 221,348 | 221,348 | 221,348 | 221,348 | 159,404 |
| End Cash Position | 222,170 | 231,271 | 241,302 | 247,082 | 221,348 |
| Net Cash Flow | $822 | $9,923 | $19,954 | $25,734 | $61,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,366 | -30,024 | -20,377 | -12,153 | -35,338 |
| Capital Expenditure | -2,412 | -1,488 | -1,126 | -122 | -2,992 |
| Free Cash Flow | -40,778 | -31,512 | -21,503 | -12,275 | -38,330 |